83 related articles for article (PubMed ID: 18348114)
1. Betablockers at work: the crystal structure of the beta2-adrenergic receptor.
Hausch F
Angew Chem Int Ed Engl; 2008; 47(18):3314-6. PubMed ID: 18348114
[No Abstract] [Full Text] [Related]
2. Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery.
Topiol S; Sabio M
Bioorg Med Chem Lett; 2008 Mar; 18(5):1598-602. PubMed ID: 18243704
[TBL] [Abstract][Full Text] [Related]
3. Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor.
de Graaf C; Rognan D
J Med Chem; 2008 Aug; 51(16):4978-85. PubMed ID: 18680279
[TBL] [Abstract][Full Text] [Related]
4. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry. Signaling across the cell membrane.
Ranganathan R
Science; 2007 Nov; 318(5854):1253-4. PubMed ID: 18033872
[No Abstract] [Full Text] [Related]
6. Crystallizing thinking about the beta2-adrenergic receptor.
Shukla AK; Sun JP; Lefkowitz RJ
Mol Pharmacol; 2008 May; 73(5):1333-8. PubMed ID: 18239031
[TBL] [Abstract][Full Text] [Related]
7. Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.
Sabio M; Jones K; Topiol S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5391-5. PubMed ID: 18829308
[TBL] [Abstract][Full Text] [Related]
8. A structure activity relationship study on 1-isopropylamino-3-(2'-substituted naphthoxy)-propan-2-ois analogs.
Srivastava AK; Mishra N; Khan AA; Gupta DK
Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):351-4. PubMed ID: 7827810
[TBL] [Abstract][Full Text] [Related]
9. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6.
Hattori K; Orita M; Toda S; Imanishi M; Itou S; Nakajima Y; Tanabe D; Washizuka K; Araki T; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
Bioorg Med Chem Lett; 2009 Aug; 19(16):4679-83. PubMed ID: 19608416
[TBL] [Abstract][Full Text] [Related]
10. Ligand entry and exit pathways in the beta2-adrenergic receptor.
Wang T; Duan Y
J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
[TBL] [Abstract][Full Text] [Related]
11. Insights into signaling from the beta2-adrenergic receptor structure.
Audet M; Bouvier M
Nat Chem Biol; 2008 Jul; 4(7):397-403. PubMed ID: 18560432
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
13. An efficient asymmetric synthesis of the potent beta-blocker ICI-118,551 allows the determination of enantiomer dependency on biological activity.
Baker JR; Hothersall JD; Fitzmaurice RJ; Tucknott M; Vinter A; Tinker A; Caddick S
Chem Commun (Camb); 2010 Jun; 46(22):3953-4. PubMed ID: 20431838
[TBL] [Abstract][Full Text] [Related]
14. Switching modes for G protein-coupled receptor activation.
Vilardaga JP
Nat Chem Biol; 2006 Aug; 2(8):395-6. PubMed ID: 16850011
[No Abstract] [Full Text] [Related]
15. Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity.
Selvam B; Wereszczynski J; Tikhonova IG
Chem Biol Drug Des; 2012 Aug; 80(2):215-26. PubMed ID: 22530954
[TBL] [Abstract][Full Text] [Related]
16. Structural biology: a receptor unlocked.
Sprang SR
Nature; 2007 Nov; 450(7168):355-6. PubMed ID: 18004367
[No Abstract] [Full Text] [Related]
17. Synthesis and pharmacological characterization of beta2-adrenergic agonist enantiomers: zilpaterol.
Kern C; Meyer T; Droux S; Schollmeyer D; Miculka C
J Med Chem; 2009 Mar; 52(6):1773-7. PubMed ID: 19245211
[TBL] [Abstract][Full Text] [Related]
18. A crystal clear view of the beta2-adrenergic receptor.
Lefkowitz RJ; Sun JP; Shukla AK
Nat Biotechnol; 2008 Feb; 26(2):189-91. PubMed ID: 18259173
[No Abstract] [Full Text] [Related]
19. Synthesis and in vitro evaluation of derivatives of the β₁-adrenergic receptor antagonist HX-CH 44.
Stephenson KA; Wilson AA; Houle S; Vasdev N
Bioorg Med Chem Lett; 2011 Sep; 21(18):5506-9. PubMed ID: 21783363
[TBL] [Abstract][Full Text] [Related]
20. Synthetic and endogenous beta-adrenergic receptor antagonists--comparative pharmacological characterization.
Temnyalov ND
Auton Neurosci; 2009 Jun; 148(1-2):16-20. PubMed ID: 19328045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
